The human receptor tyrosine kinase Axl gene--promoter characterization and regulation of constitutive expression by Sp1, Sp3 and CpG methylation - PubMed (original) (raw)

The human receptor tyrosine kinase Axl gene--promoter characterization and regulation of constitutive expression by Sp1, Sp3 and CpG methylation

Giridhar Mudduluru et al. Biosci Rep. 2008 Jun.

Abstract

Axl is a receptor tyrosine kinase which promotes anti-apoptosis, mitogenesis, invasion, angiogenesis and metastasis, and is highly expressed in cancers. However, the transcriptional regulation of this important gene has never been characterized. The present study was initiated to characterize the promoter, cis-acting elements and promoter methylation driving expression of Axl. The 2.4 kb sequence upstream of the translational start site, and sequential 5'-deletions were cloned and revealed a minimal GC-rich region (-556 to +7) to be sufficient for basal Axl promoter activity in Rko, HCT116 and HeLa cells. Within this minimal region, five Sp (specificity protein)-binding sites were identified. Two sites (Sp a and Sp b) proximal to the translation start site were indispensable for Axl promoter activity, whereas mutation of three additional upstream motifs (Sp c, Sp d and Sp e) was of additional relevance. Gel-shift assays and chromatin immunoprecipitation identified that Sp1 and Sp3 bound to all five motifs, and mutation of all motifs abolished binding. Mithramycin, which inhibits binding of Sp factors to GC-rich sites, dramatically reduced Axl promoter activity and Axl, Sp1 and Sp3 expression. In Drosophila Schneider SL2-cells, exogenous expression of Sp1/Sp3 increased Axl promoter activity. Use of Sp1/Sp3 siRNAs (small interfering RNAs) significantly reduced Axl promoter activity and protein levels in Rko and HeLa cells. Methylation-bisulfite sequencing detected methylated CpG sites within three Sp motifs (Sp a, Sp b and Sp c) and GC-rich flanking sequences, and demethylation by 5-aza-2'-deoxycytidine up-regulated Axl and Sp3 expression in low-Axl-expressing Colo206f/WiDr cells, but not in high-Axl-expressing Rko cells. The results of the present study suggest that Axl gene expression in cancer cells is (1) constitutively driven by Sp1/Sp3 bound to five core promoter motifs, and (2) restricted by methylation within/around Sp-binding sites. This might enhance the understanding and treatment of essential mechanisms associated with cancer and other diseases.

PubMed Disclaimer

Cited by

MACC1 is post-transcriptionally regulated by miR-218 in colorectal cancer.
Ilm K, Fuchs S, Mudduluru G, Stein U. Ilm K, et al. Oncotarget. 2016 Aug 16;7(33):53443-53458. doi: 10.18632/oncotarget.10803. Oncotarget. 2016. PMID: 27462788 Free PMC article.
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer.
Collina F, La Sala L, Liotti F, Prevete N, La Mantia E, Chiofalo MG, Aquino G, Arenare L, Cantile M, Liguori G, Di Gennaro F, Pezzullo L, Losito NS, Vecchio G, Botti G, Melillo RM, Franco R. Collina F, et al. Cancers (Basel). 2019 Jun 7;11(6):785. doi: 10.3390/cancers11060785. Cancers (Basel). 2019. PMID: 31181609 Free PMC article.
MicroRNAs in lung cancer.
Joshi P, Middleton J, Jeon YJ, Garofalo M. Joshi P, et al. World J Methodol. 2014 Jun 26;4(2):59-72. doi: 10.5662/wjm.v4.i2.59. eCollection 2014 Jun 26. World J Methodol. 2014. PMID: 25332906 Free PMC article. Review.
TAM receptors in leukemia: expression, signaling, and therapeutic implications.
Brandão L, Migdall-Wilson J, Eisenman K, Graham DK. Brandão L, et al. Crit Rev Oncog. 2011;16(1-2):47-63. doi: 10.1615/critrevoncog.v16.i1-2.60. Crit Rev Oncog. 2011. PMID: 22150307 Free PMC article.
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications.
Zhu C, Wei Y, Wei X. Zhu C, et al. Mol Cancer. 2019 Nov 4;18(1):153. doi: 10.1186/s12943-019-1090-3. Mol Cancer. 2019. PMID: 31684958 Free PMC article. Review.

The human receptor tyrosine kinase Axl gene--promoter characterization and regulation of constitutive expression by Sp1, Sp3 and CpG methylation - PubMed (original) (raw)